If DR5 agonist stabilize PD‐L1 via proteasome inactivation, we hypothesized significantly higher degradation of proteasome regulatory submits in DR5‐WT tumor cell lines as compared to DR5‐KO cells upon DR5 agonist treatments. This evidence concerns the gene CD274 and neoplasm.